Azonal steatosis correlates with disease severity and poor outcome of nonalcoholic fatty liver disease.

Azonal steatosis distribution is associated with greater disease activity and fibrosis stage in NAFLD patients, and predisposes toward poor outcomes. PNPLA3 rs738409 with CG/GG genotype and age are two independent predictors for azonal steatosis in NAFLD patients. This article is protected by copyright. All rights reserved.